BCAX
$18.35+5.04%
Bicara Therapeutics Inc.Stock · HealthcareRussell 2000 · 0.04% of IWMNasdaq Composite · 0.005% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.001% of IWV
Bicara Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 20, 2026
Bicara Therapeutics Inc. total returns by year (2025–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $16.83 | $18.35 | 0.0% | +9.0% | |
| 2025 | $17.42 | $16.83 | 0.0% | -3.4% |
- Annualized
- -14.8%
- 2025–2026
- Average year
- -3.4%
- 1 full years
- Best year
- -3.4%
- 2025
- Worst year
- -3.4%
- 2025
- Positive years
- 0/1
- 0% up
Annualized (CAGR)
-14.8%
2025–2026
Average year
-3.4%
1 full years
Best year
-3.4%
2025
Worst year
-3.4%
2025
Positive years
0/1
0% up
Total return by period#
Annual
-5%0%5%
2025-3.4%'25
2026+9.0%'26
Methodology#
Total returns, dividends reinvested, measured on BCAX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Bicara Therapeutics Inc.'s average annual return?
- Since 2025, Bicara Therapeutics Inc. (BCAX) has returned about -14.8% a year (the compound annual growth rate) and an average calendar-year return of -3.4%.
- What were Bicara Therapeutics Inc.'s best and worst years?
- Over 2025–2026, the best year was 2025 (-3.4%) and the worst was 2025 (-3.4%).
- How often is Bicara Therapeutics Inc. up in a year?
- 0 of the 1 full years since 2025 were positive — about 0% of the time.
More on Bicara Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100